The author stresses that the results have been largely disappointing and are awaiting new active agents and models with which the most effective use of the agents available could be established. This is a book concentrating on human malignancy written for clinicians, and provides a readable account of a complicated field which continues to develop rapidly. It rightly stresses that our knowledge is incomplete, and provides a useful introduction to tumour immunology. A number of texts on this subject have recently appeared, and the lack of a thorough consideration of the animal model and effector mechanisms makes this one less attractive as a book for general recommendation.
B This volume is a comprehensive collection, compiled by the UICC, of all clinical trials registered with the UICC information office by June 1977. The plan of data collection is outlined in the introduction to the book, and thereafter a series of tables defines the trial according to the disease site, with further details on the protocol and of the relevant investigating unit. One of the major shortcomings in this volume is the lack of crossreference by means of an author index but, none the less, for any group of practising clinical research oncologists this is an important summary of currently registered ongoing trials in malignant disease. Although it is unlikely that any individual would want to possess such a volume, it will be an invaluable reference for an oncological library.
H So rapid has been the expansion of our knowledge of the immunopathology of lymphoreticular neoplasia that it seems scarcely 10 years since the discussion of these malignancies was dominated exclusively by morphological considerations and clinical matters. The combined fields of immunology, cytochemistry and immunochemistry have opened new approaches wNhich have quickly proved applicable to the study of lymphomas. The cytoidentity of primary neoplastic cells is nowr more clearly recognized and their clonal nature has been established. More subtle immunological perturbations have also become apparent.
This voluine lives up to the title of the series of which it is the 4th of 5 parts (to date), in that the degree of coverage approaches monumental proportions. An initial series of chapters provides the normal structural and functional framewNork for the aberrations of the lymphoid system wrhich follow%. These include contributions on lymphoid-tissue development, immunoregulation and ageing and involution of the immune apparatus.
The high frequency of cancers in patients with either primary genetically determined or iatrogenic immunodeficiency is discussed in excellent chapters by B. Spector and colleagues, and I. Penn respectively. In the former, the results of an international effort to collect data on cancers in patients with primary immunodeficiences are presented, and in the latter there is the encouraging fact that disseminated cancers arising from malignant cells inadvertently present in transplanted organs, can be eradicated on restoration of immune function.
The application of the marker techniques wNrhich have provided new criteria of classification and analysis is discussed in 2 lucid chapters by F. P. Seigal (Cytoidentity of lymphoreticular neoplasias) and E. C. Franklin and J. Buxbaum (Immunoglobulins in the normal state and in neoplasias of B cells). These contributions provide the rationale for eventual prevention and improved treatment, particularly since the technical advances therein described now make it possible in some instances to identify the cell of origin of the lymphomas.
This volume also contains a number of presentations which should be useful to the clinician. S. A. Rosenberg contributes a chapter on the Treatment of Primary Lymphoid Neoplasias, and elsewhere in the book Hodgkin's Disease receives much attention. Perhaps of greatest clinical interest, however, is a chapter (by R. H. Marshak ande.colleagues)
